AlzChem Group Valuation

ACT Stock  EUR 61.60  0.60  0.96%   
At this time, the firm appears to be overvalued. AlzChem Group AG shows a prevailing Real Value of €55.44 per share. The current price of the firm is €61.6. Our model approximates the value of AlzChem Group AG from analyzing the firm fundamentals such as Price To Sales of 0.35 X, ebitda of 62.69 M, and Current Valuation of 256.64 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
61.60
Please note that AlzChem Group's price fluctuation is very steady at this time. Calculation of the real value of AlzChem Group AG is based on 3 months time horizon. Increasing AlzChem Group's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the AlzChem stock is determined by what a typical buyer is willing to pay for full or partial control of AlzChem Group AG. Since AlzChem Group is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AlzChem Stock. However, AlzChem Group's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  61.6 Real  55.44 Hype  61.6
The real value of AlzChem Stock, also known as its intrinsic value, is the underlying worth of AlzChem Group AG Company, which is reflected in its stock price. It is based on AlzChem Group's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of AlzChem Group's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
55.44
Real Value
67.76
Upside
Estimating the potential upside or downside of AlzChem Group AG helps investors to forecast how AlzChem stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AlzChem Group more accurately as focusing exclusively on AlzChem Group's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
58.4861.6064.72
Details

AlzChem Group Total Value Analysis

AlzChem Group AG is presently anticipated to have takeover price of 256.64 M with market capitalization of 256.64 M, debt of 37.55 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the AlzChem Group fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
256.64 M
256.64 M
37.55 M

AlzChem Group Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of AlzChem indicates not a very effective usage of assets in January.

AlzChem Group Profitability Analysis

The company reported the revenue of 422.29 M. Net Income was 27.59 M with profit before overhead, payroll, taxes, and interest of 0.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AlzChem Group's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AlzChem Group and how it compares across the competition.

About AlzChem Group Valuation

The stock valuation mechanism determines AlzChem Group's current worth on a weekly basis. Our valuation model uses a comparative analysis of AlzChem Group. We calculate exposure to AlzChem Group's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AlzChem Group's related companies.

8 Steps to conduct AlzChem Group's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates AlzChem Group's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct AlzChem Group's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain AlzChem Group's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine AlzChem Group's revenue streams: Identify AlzChem Group's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research AlzChem Group's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish AlzChem Group's growth potential: Evaluate AlzChem Group's management, business model, and growth potential.
  • Determine AlzChem Group's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate AlzChem Group's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for AlzChem Stock analysis

When running AlzChem Group's price analysis, check to measure AlzChem Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AlzChem Group is operating at the current time. Most of AlzChem Group's value examination focuses on studying past and present price action to predict the probability of AlzChem Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AlzChem Group's price. Additionally, you may evaluate how the addition of AlzChem Group to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets